This study is testing whether a newer type of diabetes drug (a GIP/GLP-1 receptor agonist) can improve heart function and blood sugar control in adults who have both chronic heart failure and type 2 diabetes. About 120 participants in Kazakhstan will receive the drug and be monit…
Phase: NA • Sponsor: Nazarbayev University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC